tradingkey.logo

Envoy Medical Inc

COCH
查看詳細走勢圖
0.733USD
+0.033+4.67%
收盤 12/19, 16:00美東報價延遲15分鐘
17.45M總市值
虧損本益比TTM

Envoy Medical Inc

0.733
+0.033+4.67%
盤中分時
1分
30分
1小時
日k
週k
月k
日k

今天

+4.67%

5天

-9.03%

1月

+5.09%

6月

-47.66%

今年開始到現在

-48.76%

1年

-55.59%

查看詳細走勢圖

TradingKey Envoy Medical Inc股票評分

單位: USD 更新時間: 2025-12-19

操作建議

Envoy Medical Inc當前公司基本面數據相對穩定,增長潛力較大。當前估值合理,在醫療設備與耗材行業排名138/208位。機構持股佔比非常高,近一個月多位分析師給出公司評級為買入。最高目標價8.25。中期看,股價處於下降通道。近一個月,市場表現一般,基本面和技術面綜合得分也較低。目前股價在壓力位和支撐位之間,可以做區間波段操作。

Envoy Medical Inc評分

相關信息

行業排名
138 / 208
全市場排名
338 / 4582
所屬行業
醫療設備與耗材

壓力支撐

由於公司未披露,未能獲取相關數據

多維評測

本期評分
上期評分

分析師目標

基於 2 分析師
買入
評級
8.250
目標均價
+889.92%
漲幅空間
數據免責聲明:分析師評級與目標價由LSEG提供,僅供參考,不應當作投資建議

Envoy Medical Inc亮點

亮點風險
Envoy Medical, Inc. is a hearing health company. The Company is engaged in providing medical technologies across the hearing loss spectrum, all designed to shift the paradigm within the hearing industry and bring both providers and patients the hearing devices they require. Its hearing solutions include hearing aids, middle ear implants, bone conduction devices and cochlear implants. The bone conduction hearing device has two components: an external component and a surgically implanted fixture placed in the bone behind the ear. Its bone conduction hearing device offers amplification without ear mold in the ear. Its hearing aids are devices that amplify sound for those with mild to moderate hearing loss. Its Esteem is a fully implanted active middle ear implant designed to improve the hearing of adults diagnosed with moderate to severe sensorineural hearing loss. Cochlear implants are a solution for people with moderate-to-profound sensorineural hearing loss.
業績增長期
公司處於發展階段,最新年度總收入225.00K美元
利潤高增長
公司淨利潤處於行業前列,最新年度總收入225.00K美元
估值高估
公司最新PE估值-0.51,處於3年歷史高位
機構加倉
最新機構持股2.25M股,環比增加3.48%
先鋒集團持倉
明星投資者先鋒集團持倉,最新持倉339.11K股
活躍度增加
近期活躍度增加,過去20天平均換手率3.14

Envoy Medical Inc新聞

即將為您帶來更多新聞,敬請期待。 。 。

財務指標

每股收益

由於公司未披露,未能獲取相關數據

營業總收入

由於公司未披露,未能獲取相關數據

Envoy Medical Inc簡介

Envoy Medical, Inc. is a hearing health company. The Company is engaged in providing medical technologies across the hearing loss spectrum, all designed to shift the paradigm within the hearing industry and bring both providers and patients the hearing devices they require. Its hearing solutions include hearing aids, middle ear implants, bone conduction devices and cochlear implants. The bone conduction hearing device has two components: an external component and a surgically implanted fixture placed in the bone behind the ear. Its bone conduction hearing device offers amplification without ear mold in the ear. Its hearing aids are devices that amplify sound for those with mild to moderate hearing loss. Its Esteem is a fully implanted active middle ear implant designed to improve the hearing of adults diagnosed with moderate to severe sensorineural hearing loss. Cochlear implants are a solution for people with moderate-to-profound sensorineural hearing loss.
公司代碼COCH
公司Envoy Medical Inc
CEOLucas (Brent T)
網址https://www.envoymedical.com/

常見問題

Envoy Medical Inc(COCH)的當前股價是多少?

Envoy Medical Inc(COCH)的當前股價是 0.733。

Envoy Medical Inc 的股票代碼是什麼?

Envoy Medical Inc的股票代碼是COCH。

Envoy Medical Inc股票的52週最高點是多少?

Envoy Medical Inc股票的52週最高點是2.000。

Envoy Medical Inc股票的52週最低點是多少?

Envoy Medical Inc股票的52週最低點是0.640。

Envoy Medical Inc的市值是多少?

Envoy Medical Inc的市值是17.45M。

Envoy Medical Inc的淨利潤是多少?

Envoy Medical Inc的淨利潤為-27.97M。

現在Envoy Medical Inc(COCH)的股票是買入、持有還是賣出?

根據分析師評級,Envoy Medical Inc(COCH)的總體評級為買入,目標價格為8.250。

Envoy Medical Inc(COCH)股票的每股收益(EPS TTM)是多少

Envoy Medical Inc(COCH)股票的每股收益(EPS TTM)是-1.426。
KeyAI